Theravance Biopharma, Inc. (TBPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 941.43M |
| Enterprise Value | 849.12M |
| P/E Ratio | 7.44 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 7.91 |
| Price/Book Ratio | 2.97 |
| Enterprise/Revenue | 5.95 |
| Enterprise/EBITDA | 4.59 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 1.04 |
| Operating Margin | 0 |
| Return On Assets | 0.24 |
| Return On Equity | 0.44 |
| Revenue | 107.46M |
| Revenue/Share | 2.14 |
| Gross Profit | 101.95M |
| EBITDA | 137.22M |
| Net Income | 105.9M |
| Diluted EPS | 2.06 |
| Total Cash | 394.67M |
| Total Cash/Share | 7.7 |
| Total Debt | 73.3M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 13.14 |
| Book Value Per Share | 5.67 |
| 52-Week Change | 59.37 |
| 52-Week High | 21.03 |
| 52-Week Low | 10.46 |
| Moving Average 50 Days | 16.51 |
| Moving Average 200 Days | 16.66 |
| Average Volume | 414,770 |
| Shares Outstanding | 51.55M |
| % Held by Institutions | 99.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |